AstraZeneca Plc’s new nasal spray vaccine designed to prevent seasonal flu has been given a positive opinion by the European Medicine Agency’s main scientific committee, the Committee for Medicinal Products for Human Use. ---Subscribe to MedNous to access this article--- Regulation & Policy
